Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry

European Heart Journal

Volumn 30, Issue 10, 2009, Pages 1171-1179

  Tamburino, Corrado ^a   Di Salvo, Maria Elena ^a   Capodanno, Davide ^a   Marzocchi, Antonio ^b   Sheiban, Imad ^c   Margheri, Massimo ^d   Maresta, Aleardo ^e   Barlocco, Fabio ^f   Sangiorgi, Giuseppe ^g   Piovaccari, Giancarlo ^h   Bartorelli, Antonio ⁱ   Briguori, Carlo ^j   Ardissino, Diego ^j   Di Pede, Francesco ^k   Ramondo, Angelo ^l   Inglese, Luigi ^m   Petronio, Anna Sonia ⁿ   Bolognese, Leonardo ^m   Benassi, Alberto ^o   Palmieri, Cataldo ^p   Patti, Aldo ^q   De Servi, Stefano ^f   more..

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Divisione di Cardiologia   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^f Ospedale Civile   (Italy)

^g EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^h OSPEDALE DEGLI INFERMI   (Italy)

ⁱ CENTRO CARDIOLOGICO MONZINO   (Italy)

^j Clinica Mediterranea   (Italy)

^k Ospedale Civile   (Italy)

^l UNIVERSITY OF PADOVA   (Italy)

^m IRCCS POLICLINICO SAN DONATO   (Italy)

ⁿ CISANELLO HOSPITAL   (Italy)

^o HESPERIA HOSPITAL   (Italy)

^p CNR   (Italy)

^q VILLA SOFIA CERVELLO HOSPITAL   (Italy)

more..

Author keywords

Drug eluting stent; Restenosis; Unprotected left main

Indexed keywords

ADULT; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; RISK REDUCTION; STENT THROMBOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; ITALY; MALE; METALS; MIDDLE AGED; REGISTRIES; STENTS; TREATMENT OUTCOME;

EID: 66249125959     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp052     Document Type: Article

References (40)

1. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, Morrison DA, O'Neil WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:1 -121.
2. King SB III, Smith SC, Hirshfeld JW, Jacobs AK, Morrison DA, Williams DO. 2007 Focused Update of the ACC/AHA/SCAI. 2005 Guideline update for percutaneous coronary intervention. J Am Coll Cardiol 2008;51:172-209.
3. Silbert S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug J-E, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions. The Task Force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26: 804-847.
4. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, Taylor HA, Chaitman BR. Comparison of surgical and medical group survival in patients with left main coronary artery disease: long-term CASS experience. Circulation 1995; 91:2325-2334.
5. D'Allonnes FR, Corbineau H, Le Breton H, Leclercq C, Leguerrier A, Daubert C. Isolated left main coronary artery stenosis: long-term follow up in 106 patients after surgery. Heart 2002;87:544. -548.
6. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC. ACC/AHA 2004 Guidelines update for coronary artery bypass graft surgery. Circulation 2004;110:1168-1176.
7. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. Stents versus coronary artery bypass grafting for left main coronary artery disease. N EnglJ Med 2008;358:1781-1792.
8. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, Airoldi F, Carlino M, Michev I, Melzi G, Sangiorgi G, Alfieri O, Colombo A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006;113: 2542-2547.
9. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N, Trento A, Shah PK, Makkar RR. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-870.
10. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C, Bacchi-Reggiani L, Gianstefani S, Virzi S, Manara F, Kiros Weldeab M, Marinelli G, Di Bartolomeo R, Branzi A. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006;98: 54-59.
11. De Lezo JS, Medina A, Pan M, Delgado A, Segura J, Pavlovic D, Melian F, Romero M, Burgos L, Hernandez E, Urena I, Herrador J. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am Heart J 2004;148:481-485.
12. Silvestri M, Barragan P, Sainsous J, Bayet G, Simeoni JB, Roquebert PO, Macaluso G, Bouvier JL, Comet B. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol 2000;35:1543-1550.
13. Takagi T, Stankovic G, Finci L, Toutouzas K, Chieffo A, Spanos V, Liistro F, Briguori C, Corvaja N, Albero R, Sivieri G, Paloschi R, Di Mario C, Colombo A. Results and longterm predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation 2002;106:698-702.
14. Tan WA, Tamai H, Park SJ, Plokker HW, Nobuyoshi M, Suzuki T, Colombo A, Macaya C, Holmes DRJr, Cohen DJ, Withlow PL, Ellis SG. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 2001;104:1609-1614.
15. Valgimigli M, van Mieghem CA, Ong AT, Aoki J, Granillo GA, McFadden EP, Kappetein AP, de Feyter PJ, Smits PC, Regar E, Van der Giessen WJ, Sianos G, de Jaegere P, Van Domburg RT, Serruys PW. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH and T-SEARCH) registries. Circulation 2005;111:1383-1389.
16. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, Kim JJ, Mintz GS, Park SW. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 2005; 45:351-356.
17. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, Airoldi F, Michev I, Sangiorgi MG, Carlino M, Vitrella G, Colombo A. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005;111:791-795.
18. Valgimigli M, van Mieghem CAG, Ong ATL, Aoki J, Rodriguez Granillo GA, McFadden EP, Pieter Kappetein A, de Feyter PJ, Smits PC, Regar E, Van der Giessen WJ, Sianos G, de Jaegere P, Van Domburg RT, Serruys PW. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH). Circulation 2005;111:1383- 1389.
19. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg1999;16:9-13.
20. Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Sangiorgi D, De Servi S. Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology. Am J Cardiol 2008;102:1463-1468.
21. Rosembaum PR, Rubin DB. The central role of propensity score in observational studies for causal effects. Biometrica 1983;70:41- 55.
22. Rosembaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity scores. J Am Stat Assoc 1984;79:516-524.
23. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757-763.
24. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-1235.
25. Tamburino C. Elenco generale delle procedure effettuate nei laboratori italiani nel 2007. Giornale Italiano di Cardiol Invasiva 2008;3:12-29.
26. Lefevre T, Silvestri M, Bedossa M, Eltchainoff H, Brunel P, Koning R, Chevalier B. The French Registry of unprotected left main coronary artery treatment. Am J Cardiol 2003;92(suppl.):31L.
27. Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia HM, Polad J, Tsuchida K, Regar E, Van der Giessen WJ, De Jaegere P, De Feyter P, Serruys PW. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era. An integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) Registries. J Am Coll Cardiol 2006;47:1530-1537.
28. Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, Truffa A, Montorfano M, Airoldi F, Sangiorgi G, Carlino M, Michev I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Rogacka R, Serruys PW, Colombo A. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery. A multicenter registry. Circulation 2007;116:158-162.
29. Wood FO, Saylors E, Schneider JE, Jobe RL, Tift Mann J. Unprotected left main disease managed with drug-eluting stents: long term outcome of 100 patients with increased surgical risk. Cath Cardiol Int 2008;71:533-538.
30. Beauford RB, Saunders CR, Lunceford TA, Niemeier LA, Shah S, Karanam R, Prendergast T, Burns P, Sardari F, Goldstein DJ. Multivessel off-pump revascularization in patients with significant left main coronary artery stenosis: early and midterm outcome analysis. J Card Surg 2005;20:112-118.
31. Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, Migliorini A, Antoniucci D, Carrie D, Sangiorgi G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, Sheiban I. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J 2008;155:274-283.
32. Holm F, Lubanda JC, Semrad M, Rohac J, Vondracek V, Miler I, Vanek I, Golan L, Aschermann M. Main clinical and surgical determinants of in-hospital mortality after surgical revascularization of left main coronary artery stenosis: 2 year retrospective study (1998-1999). J Mal Vasc 2004;29:89-93.
33. Lu JC, Grayson AD, Pullan DM. On-pump versus off-pump surgical revascularization for left main stem stenosis: risk adjusted outcomes. Ann Thorac Surg 2005;80: 136-142.
34. Sheiban I, Meliga E, Moretti C, Fumagalli A, Omede P, Sciuto F, Grossomarra W, Trevi G. Sirolimus-eluting stents vs. bare metal stents for the treatment of unprotected left main coronary artery stenosis. Eurointervention 2006;2:356-362.
35. Chieffo A, Colombo A. Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial? Nat Clin Pract Cardiovasc Med 2005;2:396-400.
36. Li M, Zhang Y, Ren H, Zhang Y, Zhu X. Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis 2007;194: 348-356.
37. Ciuffetti G, Lombardini R, Pirro M, Lupattelli G, Mannarino E. Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis. Clin Hemorheol Microcirc 2001;25:31-39.
38. Park SJ, Hong MK, Lee CW, Kim JJ, Song JK, Kang DH, Park SW, Mintz GS. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol 2001;38: 1054-1060.
39. Agostoni P, Valgimigli M, Van Mieghem CA, Rodriguez-Granillo GA, Aoki J, Ong AT, Tsuchida K, McFadden EP, Ligthart JM, Smits PC, de Jaegere P, Sianos G, Van der Giessen WJ, De Feyter P, Serruys PW. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol 2005;95:644-647.
40. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr, Mack MJ, van den Brand M, Morel MA, van Es GA, Kleijne J, Koglin J, Russell ME. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006;151:1194-1204.